COVID-19 疫苗研发：伦理问题。
COVID-19 vaccine research and development: ethical issues.
机构信息
Department of Microbiology, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia.
Medical and Health Research Ethics Committee, Faculty of Medicine Public Health and Nursing, Universitas Gadjah Mada / Dr. Sardjito General Hospital, Yogyakarta, Indonesia.
出版信息
Trop Med Int Health. 2021 Jan;26(1):14-19. doi: 10.1111/tmi.13503. Epub 2020 Oct 19.
Abstract
The achievements of vaccine research and development bring a hope to our societies that we may cope with the COVID-19 pandemic. There are two aspects that should be maintained in balance: the immediate necessity for speed of vaccine research and the inherent need for protection of research subjects, which is the foremost concern of research ethics. This narrative review highlights ethical issues in COVID-19 vaccine research and development that every stakeholder needs to be aware of and to consider.
摘要
疫苗研发的成果给我们的社会带来了一个希望，即我们可能能够应对 COVID-19 大流行。有两个方面需要保持平衡：疫苗研究的速度的迫切需要和保护研究对象的固有需要，这是研究伦理的首要关注点。本叙述性综述强调了 COVID-19 疫苗研发中每个利益相关者都需要意识到并考虑的伦理问题。
相似文献
1
COVID-19 vaccine research and development: ethical issues.COVID-19 疫苗研发：伦理问题。
Trop Med Int Health. 2021 Jan;26(1):14-19. doi: 10.1111/tmi.13503. Epub 2020 Oct 19.
2
Expanded principles of ethics and its implementation during COVID-19 vaccine trials: A scoping evidence based research synthesis.伦理原则的扩展及其在 COVID-19 疫苗试验中的实施：基于证据的研究综合概述。
Hum Vaccin Immunother. 2021 Nov 2;17(11):3843-3849. doi: 10.1080/21645515.2021.1947101. Epub 2021 Jul 15.
3
Research ethics and public trust in vaccines: the case of COVID-19 challenge trials.研究伦理与公众对疫苗的信任：以 COVID-19 挑战试验为例。
J Med Ethics. 2024 Mar 20;50(4):278-284. doi: 10.1136/medethics-2021-108086.
4
Social network-based ethical analysis of COVID-19 vaccine supply policy in three Central Asian countries.基于社交网络的中亚三国 COVID-19 疫苗供应政策的伦理分析。
BMC Med Ethics. 2022 Mar 9;23(1):21. doi: 10.1186/s12910-022-00764-1.
5
Vaccine trials during a pandemic: potential approaches to ethical dilemmas.大流行期间的疫苗试验：应对伦理困境的潜在方法。
Trials. 2021 Sep 15;22(1):628. doi: 10.1186/s13063-021-05597-8.
6
The Ethics of Human Challenge Trials Using Emerging Severe Acute Respiratory Syndrome 2 Variants.使用新型严重急性呼吸综合征2变种进行人体挑战试验的伦理问题。
J Infect Dis. 2022 Mar 15;225(6):934-937. doi: 10.1093/infdis/jiab488.
7
Ethical guidelines for deliberately infecting volunteers with COVID-19.故意感染 COVID-19 志愿者的伦理准则。
J Med Ethics. 2020 Aug;46(8):502-504. doi: 10.1136/medethics-2020-106322. Epub 2020 May 27.
8
HIV prevention research and COVID-19: putting ethics guidance to the test.HIV 预防研究与 COVID-19：检验伦理指南。
BMC Med Ethics. 2021 Jan 25;22(1):6. doi: 10.1186/s12910-021-00575-w.
9
Government Initiatives for Research Ethics During COVID-19 Pandemic in Korea.韩国 COVID-19 大流行期间的研究伦理政府倡议。
J Korean Med Sci. 2024 Apr 1;39(12):e116. doi: 10.3346/jkms.2024.39.e116.
10
Key ethical issues encountered during COVID-19 research: a thematic analysis of perspectives from South African research ethics committees.在 COVID-19 研究中遇到的关键伦理问题：南非研究伦理委员会观点的主题分析。
BMC Med Ethics. 2023 Feb 15;24(1):11. doi: 10.1186/s12910-023-00888-y.
引用本文的文献
1
COVID-19 management in patients with comorbid conditions.合并症患者的 COVID-19 管理。
World J Virol. 2025 Jun 25;14(2):102674. doi: 10.5501/wjv.v14.i2.102674.
2
Emerging technologies transforming the future of global biosecurity.新兴技术正在改变全球生物安全的未来。
Front Digit Health. 2025 Jun 4;7:1622123. doi: 10.3389/fdgth.2025.1622123. eCollection 2025.
3
Prophylactic and therapeutic vaccine development: advancements and challenges.预防性和治疗性疫苗的研发：进展与挑战。
Mol Biomed. 2024 Nov 11;5(1):57. doi: 10.1186/s43556-024-00222-x.
4
COVID-19 Vaccines: A Radiological Review of the Good, the Bad, and the Ugly.COVID-19疫苗：关于其益处、弊端及不良影响的影像学综述
Indian J Radiol Imaging. 2024 Apr 21;34(4):714-725. doi: 10.1055/s-0044-1785210. eCollection 2024 Oct.
5
COVID-19 vaccine and non-syndromic orofacial clefts in five arab countries. A case-control study.COVID-19 疫苗与五个阿拉伯国家的非综合征性口腔颌面裂：病例对照研究。
Clin Oral Investig. 2024 Jun 6;28(7):357. doi: 10.1007/s00784-024-05744-w.
6
Ethical implications of developing RNA-based therapies for cardiovascular disorders.开发用于心血管疾病的基于RNA的疗法的伦理意义。
Front Bioeng Biotechnol. 2024 Mar 15;12:1370403. doi: 10.3389/fbioe.2024.1370403. eCollection 2024.
7
Short-term side effects of COVID-19 vaccines among healthcare workers: a multicenter study in Iran.医护人员中新冠病毒疫苗的短期副作用：伊朗的一项多中心研究
Sci Rep. 2024 Feb 19;14(1):4086. doi: 10.1038/s41598-024-54450-w.
8
Integrating health belief model and theory of planned behavior to assess COVID-19 vaccine acceptance among urban slum people in Bangladesh.将健康信念模型和计划行为理论整合起来评估孟加拉国城市贫民窟人群对 COVID-19 疫苗的接受程度。
PLoS One. 2023 Dec 20;18(12):e0290412. doi: 10.1371/journal.pone.0290412. eCollection 2023.
9
Nucleic acid-based vaccine platforms against the coronavirus disease 19 (COVID-19).针对 19 型冠状病毒病（COVID-19）的核酸疫苗平台。
Arch Microbiol. 2023 Mar 30;205(4):150. doi: 10.1007/s00203-023-03480-5.
10
Ethical considerations of the vaccine development process and vaccination: a scoping review.疫苗研发和接种过程中的伦理考量：范围综述。
BMC Health Serv Res. 2023 Mar 14;23(1):255. doi: 10.1186/s12913-023-09237-6.
本文引用的文献
1
Key criteria for the ethical acceptability of COVID-19 human challenge studies: Report of a WHO Working Group.COVID-19 人体挑战研究的伦理可接受性的关键标准：世卫组织工作组的报告。
Vaccine. 2021 Jan 22;39(4):633-640. doi: 10.1016/j.vaccine.2020.10.075. Epub 2020 Oct 28.
2
ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques.ChAdOx1 nCoV-19 疫苗可预防恒河猴的 SARS-CoV-2 肺炎。
Nature. 2020 Oct;586(7830):578-582. doi: 10.1038/s41586-020-2608-y. Epub 2020 Jul 30.
3
An mRNA Vaccine against SARS-CoV-2 - Preliminary Report.mRNA 疫苗对 SARS-CoV-2 的作用-初步报告。
N Engl J Med. 2020 Nov 12;383(20):1920-1931. doi: 10.1056/NEJMoa2022483. Epub 2020 Jul 14.
4
Accelerating Development of SARS-CoV-2 Vaccines - The Role for Controlled Human Infection Models.加速严重急性呼吸综合征冠状病毒2（SARS-CoV-2）疫苗的研发——人体感染控制模型的作用
N Engl J Med. 2020 Sep 3;383(10):e63. doi: 10.1056/NEJMp2020076. Epub 2020 Jul 1.
5
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections.无症状 SARS-CoV-2 感染的临床和免疫学评估。
Nat Med. 2020 Aug;26(8):1200-1204. doi: 10.1038/s41591-020-0965-6. Epub 2020 Jun 18.
6
Current global vaccine and drug efforts against COVID-19: Pros and cons of bypassing animal trials.当前全球针对 COVID-19 的疫苗和药物研发：绕过动物试验的利弊。
J Biosci. 2020;45(1). doi: 10.1007/s12038-020-00053-2.
7
Dengue Fever, COVID-19 (SARS-CoV-2), and Antibody-Dependent Enhancement (ADE): A Perspective.登革热、COVID-19（SARS-CoV-2）和抗体依赖性增强（ADE）：一个视角。
Cytometry A. 2020 Jul;97(7):662-667. doi: 10.1002/cyto.a.24047. Epub 2020 Jun 7.
8
COVID-19 human challenge studies: ethical issues.COVID-19 人体挑战研究：伦理问题。
Lancet Infect Dis. 2020 Aug;20(8):e198-e203. doi: 10.1016/S1473-3099(20)30438-2. Epub 2020 May 29.
9
Immunogenicity of a DNA vaccine candidate for COVID-19.针对 COVID-19 的 DNA 疫苗候选物的免疫原性。
Nat Commun. 2020 May 20;11(1):2601. doi: 10.1038/s41467-020-16505-0.
10
Animal models for emerging coronavirus: progress and new insights.新兴冠状病毒的动物模型：进展与新见解。
Emerg Microbes Infect. 2020 Dec;9(1):949-961. doi: 10.1080/22221751.2020.1764871.
Zotero 插件